Darzalex Faspro™, Polivy™ and Trodelvy™ require prior authorization for URMBT members with Blue Cross non-Medicare plans, starting Dec. 3
For dates of service on or after Dec. 3, 2021, the following drugs covered under the medical benefit will require prior authorization through AIM Specialty Health®:
Prior authorization is required when these drugs are administered to UAW Retiree Medical Benefits Trust members with Blue Cross non-Medicare plans in outpatient settings.
Note: This requirement doesn't apply to the UAW Retiree Health Care Trust (group number 70605) or the UAW International Union (group number 71714).
How to submit authorization requests
Submit prior authorization requests to AIM using one of the following methods:
More about the authorization requirements
Authorization isn't a guarantee of payment. As always, health care practitioners need to verify eligibility and benefits for members.
For additional information on requirements related to drugs covered under the medical benefit for UAW Retiree Medical Benefits Trust members with Blue Cross non-Medicare plans, see:
We'll update the appropriate drug lists to reflect the information in this message prior to the effective date.
Note: Accredo manages prior authorization requests for additional medical benefit drugs.
*Clicking this link means that you're leaving the Blue Cross Blue Shield of Michigan and Blue Care Network website. While we recommend this site, we're not responsible for its content.
Posted: September 2021
Line of business: Blue Cross Blue Shield of Michigan